| Epigenetic memory in induced pluripotent stem cells | Nature | 2010 | 1.7K |
| The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice | Journal of Experimental Medicine | 2003 | 592 |
| Comprehensive methylome map of lineage commitment from haematopoietic progenitors | Nature | 2010 | 484 |
| The therapeutic promise of the cancer stem cell concept | Journal of Clinical Investigation | 2010 | 483 |
| CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 | Journal of Experimental Medicine | 1995 | 466 |
| Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes | Nature Medicine | 1998 | 421 |
| Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis | Journal of Experimental Medicine | 2003 | 393 |
| Biomechanical forces promote embryonic haematopoiesis | Nature | 2009 | 388 |
| Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes | Diabetes | 2008 | 371 |
| CEACAM1 regulates TIM-3-mediated tolerance and exhaustion | Nature | 2015 | 350 |
| Immunosuppressive strategies in transplantation | Lancet, The | 1999 | 348 |
| Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells | Cell Stem Cell | 2010 | 336 |
| Transplantation 50 years later--progress, challenges, and promises | New England Journal of Medicine | 2004 | 317 |
| A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells | Journal of the American Society of Nephrology: JASN | 2006 | 316 |
| Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance | Journal of Experimental Medicine | 1998 | 312 |
| Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway | Journal of Experimental Medicine | 2006 | 251 |
| Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction | Transplantation | 1997 | 241 |
| MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells | Kidney International | 1990 | 200 |
| The promise and perils of stem cell therapeutics | Cell Stem Cell | 2012 | 192 |
| Regulatory CD25+ T cells in human kidney transplant recipients | Journal of the American Society of Nephrology: JASN | 2003 | 192 |
| Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation | Journal of the American Society of Nephrology: JASN | 2007 | 173 |
| COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium | American Journal of Transplantation | 2020 | 165 |
| Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo | Journal of Immunology | 2005 | 157 |
| PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection | Journal of Immunology | 2007 | 147 |
| Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality | Blood | 2013 | 141 |
